PART 2: They Fired Me From My Own Biotech Sale — Then The Buyer Read Page Eleven Out Loud-thuyhien

I thought page eleven had ended it.

I was wrong.

Paper can stop a sale.

It cannot stop people who have spent years confusing possession with truth.

The first lawsuit arrived nine days later.

Image

Not from the buyer.

Not from the board.

From my father.

He called it a petition for clarification of ownership.

Nora called it what it was.

“A tantrum in legal font.”

The complaint said I had “withheld a family-developed asset,” “misrepresented intent,” and “acted against the best interests of Helixen Biotech during a critical liquidity event.”

Family-developed.

I read that phrase three times at my kitchen table, with rain ticking against the window and my laptop still open beside a bowl of untouched soup.

Family-developed.

As if my mother had sat beside me in Cambridge while the radiator clicked all night.

As if Brent had debugged training collapse at 3:00 a.m.

As if my father had written one line of the model he later tried to sell from under me.

Nora filed our response in forty-eight hours.

Not defensive.

Surgical.

LLC filings.

Patent memos.

Source-control timestamps.

License addenda.

Board minutes.

Every redlined IP assignment my father had pushed across my desk.

Every carve-out he had ignored.

Every signature he had placed under words he never thought would matter because the person protecting them was me.

The discovery process did something I had not expected.

It didn’t just prove I owned the Helix Engine.

It exposed the family.

My mother had billed personal renovations as “investor hospitality upgrades.”

Brent had approved vendor payments to a consulting firm registered to his college roommate.

My father had used Helixen funds to cover three private loans he called “bridge obligations.”

Read More